All the information you need about Bio-Pharma & Life-Sciences Consulting to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2021-03-12 | Partially confidential | 2019-12-31 | Complete |
| 2019-11-26 | Public | 2018-12-31 | Complete |
| 2019-05-10 | Public | 2016-12-31 | Complete |
| Name | Bio-Pharma & Life-Sciences Consulting |
| Siren | 539268037 |
| Closing | 2019-12-31 |
| Registry code | 6901 |
| Registration number | B2021/008241 |
| Management number | 2012B00336 |
| Activity code | 7211Z |
| Closing date n-1 | 2018-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2021-03-12 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Partially confidential |
| Address | 69003 LYON |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AT Other tangible assets | 31 180.00 | 17 689.00 | 13 491.00 | 31 180.00 |
BH Other financial assets | 750.00 | 750.00 | 750.00 | |
BJ TOTAL (I) | 31 930.00 | 17 689.00 | 14 241.00 | 31 930.00 |
BX Customers and related accounts | 62 400.00 | 10 000.00 | 52 400.00 | 62 400.00 |
BZ Other receivables | 12 286.00 | 12 286.00 | 12 286.00 | |
CF Cash and cash equivalents | 425 541.00 | 425 541.00 | 425 541.00 | |
CH Prepaid expenses | 345.00 | 345.00 | 345.00 | |
CJ TOTAL (II) | 500 572.00 | 10 000.00 | 490 572.00 | 500 572.00 |
CO Grand total (0 to V) | 532 502.00 | 27 689.00 | 504 814.00 | 532 502.00 |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 2 000.00 | 2 000.00 | 2 000.00 | |
DD Legal reserve (1) | 200.00 | 200.00 | 200.00 | |
DG Other reserves | 78 124.00 | 35 508.00 | 78 124.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 66 132.00 | 42 616.00 | 66 132.00 | |
DL TOTAL (I) | 146 456.00 | 80 324.00 | 146 456.00 | |
DU Loans and Debts from Credit Institutions (3) | 365.00 | 365.00 | ||
DV Miscellaneous Loans and Financial Debts (4) | 8 841.00 | 4 278.00 | 8 841.00 | |
DX Trade payables and related accounts | 110 311.00 | 107 904.00 | 110 311.00 | |
DY Tax and social security liabilities | 204 137.00 | 169 246.00 | 204 137.00 | |
EA Other liabilities | 22 703.00 | 6 787.00 | 22 703.00 | |
EB Prepaid income (2) | 12 000.00 | 12 000.00 | ||
EC TOTAL (IV) | 358 357.00 | 288 214.00 | 358 357.00 | |
EE Grand total (I to V) | 504 814.00 | 368 538.00 | 504 814.00 | |
| 6 - Depreciation | Amount at beginning of year | Increase: allocation for the year | Diminution reprise | Year-end amount |
0N DEPRECIATION Grand Total | 11 897.00 | 5 792.00 | 11 897.00 | |
QU DEPRECIATION Total Tangible Fixed Assets | 11 897.00 | 5 792.00 | 11 897.00 | |
| 7 - Provisions | Amount at beginning of year | Increase: allocation for the year | Diminution reprise | Year-end amount |
6T Receivables | 10 000.00 | 10 000.00 | ||
7B Total provisions for depreciation | 10 000.00 | 10 000.00 | ||
| 8 - Receivables and payables | Gross amount | Amount within 1 year | Amount 1 to 5 years | Amount more than 5 years |
8A Miscellaneous Loans and Financial Debts | 8 841.00 | 8 841.00 | 8 841.00 | |
8B Suppliers and Related Accounts | 110 311.00 | 110 311.00 | 110 311.00 | |
8D Social Security and Other Social Organizations | 204 137.00 | 204 137.00 | 204 137.00 | |
8K Other liabilities (including liabilities related to repo transactions) | 22 703.00 | 22 703.00 | 22 703.00 | |
8L Deferred income | 12 000.00 | 12 000.00 | 12 000.00 | |
UT Other financial assets | 750.00 | 750.00 | 750.00 | |
VG Loans with a maturity of up to one year at origin | 365.00 | 365.00 | 365.00 | |
VS Prepaid expenses | 75 031.00 | 75 031.00 | 75 031.00 | |
VT TOTAL – STATEMENT OF RECEIVABLES | 75 781.00 | 75 031.00 | 750.00 | 75 781.00 |
VY TOTAL – STATEMENT OF LIABILITIES | 358 357.00 | 358 357.00 | 358 357.00 | |
